Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at growing the horizons of cytokine-based immunotherapy, specifically for cancers where cure choices remain limited. Use the links below to learn far more about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/atfx-integrates-with-blackarrow-to-enhance-trading-experience/